Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

180 Life Sciences Corp (NQ: ATNF )

2.250 -0.030 (-1.32%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about 180 Life Sciences Corp

< Previous 1 2 3 Next >
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration
Via ACCESSWIRE
180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors
Via ACCESSWIRE
180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform
Via ACCESSWIRE
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Says Recent Acquisition to Help Capitalize on ‘Tremendous’ Potential in iGaming Market
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector
Via ACCESSWIRE
180 Life Sciences Corp. - Corporate Updates
Via ACCESSWIRE
BioMedNewsBreaks — 180 Life Sciences Corp. (NASDAQ: ATNF) Provides Update on Strategic Corporate Initiatives
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
BioMedNewsBreaks — 180 Life Sciences Corp. (NASDAQ: ATNF) Appoints Omar Jimenez as Chief Financial Officer
Via Investor Brand Network
180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer
From 180 Life Sciences Corp.
Via GlobeNewswire
BioMedNewsBreaks — 180 Life Sciences Corp. (NASDAQ: ATNF) Reports on Human Clinical Trial Evaluating Solid Formulation of CBD with Enhanced Oral Uptake
Via Investor Brand Network
180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake
From 180 Life Sciences Corp.
Via GlobeNewswire
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Granted Additional Extension to Regain Compliance with Continued Nasdaq Listing Requirements
Via Investor Brand Network
180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
From 180 Life Sciences Corp.
Via GlobeNewswire
180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
From 180 Life Sciences Corp.
Via GlobeNewswire
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Regains Compliance with Nasdaq Minimum Bid Price Requirement
Via Investor Brand Network
180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
From 180 Life Sciences Corp.
Via GlobeNewswire
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Plans 1-for-19 Reverse Stock Split to Regain NASDAQ Compliance
Via Investor Brand Network
180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan
From 180 Life Sciences Corp.
Via GlobeNewswire
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Engagement of Alliance Global Partners
Via Investor Brand Network
180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives
From 180 Life Sciences Corp.
Via GlobeNewswire
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Officials, Board to Review of Strategic Alternatives
Via Investor Brand Network
180 Life Sciences Announces Review of Strategic Alternatives
From 180 Life Sciences Corp.
Via GlobeNewswire
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Closes on $3M Public Offering
Via Investor Brand Network
180 Life Sciences Corp. Announces Closing of $3 Million Public Offering
From 180 Life Sciences Corp.
Via GlobeNewswire
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Releases Public Offering Pricing, Offering Could Reach $3M
Via Investor Brand Network
180 Life Sciences Corp. Announces Pricing of $3 Million Public Offering
From 180 Life Sciences Corp.
Via GlobeNewswire
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Enters Agreement for Strategic PK Study
Via Investor Brand Network
Topics Derivatives
Exposures Derivatives
180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake
From 180 Life Sciences Corp.
Via GlobeNewswire
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Issues Update on Regulatory Approval Process for Dupuytren’s Disease Treatment
Via Investor Brand Network
180 Life Sciences Provides Update on Regulatory Approval Process in the UK and US for Dupuytren’s Disease Treatment; Continues Consultations with the UK MHRA and Initiates a Type C Meeting Request With the US FDA
From 180 Life Sciences Corp.
Via GlobeNewswire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.